| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/12/2002 | WO2001009192A9 Human monoclonal antibodies to prostate specific membrane antigen |
| 09/12/2002 | WO2001004266A9 A lung cancer associated retrovirus, gene delivery vector and methods of use thereof |
| 09/12/2002 | WO2001003729A3 Recombinant envelope vaccine against flavivirus infection |
| 09/12/2002 | WO2000073801A3 Breast, gastric and prostate cancer associated antigens and uses therefor |
| 09/12/2002 | WO2000067792A9 Monoclonal antibody directed against cells of human renal cell carcinoma |
| 09/12/2002 | WO2000066727A9 Tumour-associated antigen |
| 09/12/2002 | US20020129388 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of atherosclerosis |
| 09/12/2002 | US20020128459 Physiologically active protein originating in mammals |
| 09/12/2002 | US20020128453 Generating immunoglobulin; obtain blood sample, incubate with pepsin, remove decomposed products, recover immunoglobulins |
| 09/12/2002 | US20020128449 Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells |
| 09/12/2002 | US20020128444 Controling abberant inflamatory response; obtain animal, incubate with modulator of inflammation, monitor animal for adjustment in inflammatory response |
| 09/12/2002 | US20020128443 Polynucleotides encoding thrombin receptor homologs |
| 09/12/2002 | US20020128437 Polypeptide for use in the detection of bactericides and prevention, detect and treatment of infections |
| 09/12/2002 | US20020128436 Therapeutic composition for use in the treatment of autoimune and rheumatic diseases |
| 09/12/2002 | US20020128218 Therapeutic delivery compositions and methods of use thereof |
| 09/12/2002 | US20020128201 Tumor antigen |
| 09/12/2002 | US20020128200 Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for treating said individuals |
| 09/12/2002 | US20020128190 Expression of properly folded and soluble extracellular domain of a gonadotropin receptor |
| 09/12/2002 | US20020127718 Maturation of dendritic cells by recombinant heat shock protein 70 |
| 09/12/2002 | US20020127713 Specific tolerance in transplantation |
| 09/12/2002 | US20020127700 Methods for improved diagnosis and treatment of mycobacterial infections |
| 09/12/2002 | US20020127682 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| 09/12/2002 | US20020127676 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 09/12/2002 | US20020127668 Polypeptide for use in the diagnosis and treatment of cancer, nervous system and vessicular transport disorders |
| 09/12/2002 | US20020127655 Nucleic acids and proteins of a rat ganglioside GM1-specific alpha 1-2 fucosyltransferase and uses thereof |
| 09/12/2002 | US20020127648 Novel human C5a-like receptor |
| 09/12/2002 | US20020127645 Secretory immunoglobulin produced by single cells and methods for making and using same |
| 09/12/2002 | US20020127612 Cell proliferation polypeptide for use in the diagnosis and treatment of tumors |
| 09/12/2002 | US20020127595 Endostatin; for use as a contraceptive and in cancer treatment |
| 09/12/2002 | US20020127553 Apoptin-associating protein |
| 09/12/2002 | US20020127544 Kit for the detection of modulator which prevent viral diseases |
| 09/12/2002 | US20020127542 Pharmaceutical compositions for treating tumour diseases |
| 09/12/2002 | US20020127245 Canine coronavirus S gene and uses therefor |
| 09/12/2002 | US20020127242 To reduce the severity or prevent infection by ehrlichial parasites of the species Anaplasma marginale |
| 09/12/2002 | US20020127241 For detection, diagnosis, prevention and treatment of malaria |
| 09/12/2002 | US20020127240 Leptospiral rare outer membrane proteins |
| 09/12/2002 | US20020127239 LipL32 polypeptide is useful for inducing an immune response to a pathogenic spirochete in a patient |
| 09/12/2002 | US20020127238 Utilizing a modified HIV-1 envelope protein or fragment or DNA encoding a modified HIV-1 envelope protein or fragment, wherein modified protein having a HIV-1 envelope protein V2 region deletion |
| 09/12/2002 | US20020127235 Identification and molecular characterization of proteins, expressed in the Ixodes ricinus salivary glands |
| 09/12/2002 | US20020127234 Administering to the egg- laying vertebrate or to an egg of the vertebrate the vaccine of immunoconjugate of myostatin polypeptide linked to a carrier to increase muscle weight |
| 09/12/2002 | US20020127232 Activating alpha 2-macroglobulin by incubation with a nucleophilic compound to form nucleophile-activated alpha 2-macroglobulin, removing excess of nucleophilic compound, incubating activated alpha-2 macroglobulin with biomolecule |
| 09/12/2002 | US20020127231 Extracellular domains of a heterodimeric protein operatively linked to immunoglobulin heavy and light chain polypeptides |
| 09/12/2002 | US20020127230 Transcutaneous photodynamic therapy ("PDT") of a target tissue |
| 09/12/2002 | US20020127227 Antagonist monoclonal antibodies (mAb) that bind to the RHAMM (receptor for hyaluronic acid mediated motility) receptor; useful for preventing proliferative disease states in a mammal |
| 09/12/2002 | US20020127224 Use of photoluminescent nanoparticles for photodynamic therapy |
| 09/12/2002 | US20020127221 Urocortin proteins and uses thereof |
| 09/12/2002 | US20020127217 A polynucleotides which identify and encode Phosphatidylinositol 4,5-bisphosphate 5-phosphatase (polypeptide) |
| 09/12/2002 | US20020127209 Tripeptide of intracellular tyrosine-based activation motifs (ITAM) mediates trafficking of targets phagocytosed via Fc gamma RIIA to the lysosomal compartment |
| 09/12/2002 | US20020127208 Method of transplantation using chemotherapy-treated allogeneic cells that enhance immune responses without graft versus host disease |
| 09/12/2002 | US20020127205 Immunoregulatory molecule expressed by the cell(s) are capable of inhibiting T cell activation and/or natural killer cell-mediated immune response against the cell upon transplantation into a recipient subject |
| 09/12/2002 | US20020127188 Composition for pulmonary administration comprising a drug and a hydrophobic amino acid |
| 09/12/2002 | DE10109855A1 Polypeptide eines p53-Protein-spezifischen murinen alpha/beta T-Zell Rezeptors, diese kodierende Nukleinsäuren und deren Verwendung Polypeptide of a p53 protein specific murine alpha / beta T-cell receptor nucleic acids encoding these, and their use |
| 09/12/2002 | DE10109854A1 Polypeptide eines hdm2-Protein spezifischen murinen alpha/beta T-Zell Rezeptors, diese kodierende Nukleinsäuren und deren Verwendung Polypeptides of hdm2 protein specific murine alpha / beta T-cell receptor nucleic acids encoding these, and their use |
| 09/12/2002 | DE10109813A1 Tumor-Peptidantigen aus humanem mdm2 Proto-Onkogen Tumor antigen peptide from human MDM2 proto-oncogene |
| 09/12/2002 | DE10109618A1 Modifying antigen-presenting cells, useful e.g. in antitumor vaccines, by transfer to them of antigen-containing membrane fragments from diseased cells |
| 09/12/2002 | CA2445018A1 Tumour peptide antigen produced from human mdm2 proto-oncogene |
| 09/12/2002 | CA2445013A1 Polypeptides of an hdm2 protein-specific murine alpha/beta t-cell receptor, nucleic acids encoding these and their use |
| 09/12/2002 | CA2445004A1 Polypeptides of a p53 protein-specific murine alpha/beta t-cell receptor, nucleic acids encoding these and their use |
| 09/12/2002 | CA2441476A1 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 09/12/2002 | CA2440513A1 Nucleic acids for transforming fish cells and methods for their use |
| 09/12/2002 | CA2439990A1 Immunogenic hiv peptides for use as reagents and vaccines |
| 09/12/2002 | CA2439941A1 Secreted proteins |
| 09/12/2002 | CA2439934A1 Use of protein histidine phosphatase |
| 09/12/2002 | CA2439933A1 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 09/12/2002 | CA2439852A1 Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| 09/12/2002 | CA2439802A1 Immune response potentiation |
| 09/12/2002 | CA2439628A1 Vaccine |
| 09/12/2002 | CA2439625A1 Compositions of multimeric profilin for diagnosis and treatment of allergies |
| 09/12/2002 | CA2439594A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 09/12/2002 | CA2439205A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439203A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439200A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439197A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439196A1 Nuclear hormone receptor ligand binding domains |
| 09/12/2002 | CA2439195A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439192A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2438505A1 Altered peptide ligands |
| 09/12/2002 | CA2433933A1 Use of lp82 to treat hematopoietic disorders |
| 09/12/2002 | CA2432280A1 Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor |
| 09/12/2002 | CA2431500A1 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
| 09/11/2002 | EP1239038A1 High-throughput identification of modulators of e2f activity |
| 09/11/2002 | EP1239036A1 Polynucleotides, polypeptides, remedies for cancer and vaccines |
| 09/11/2002 | EP1239032A1 Lactic acid bacteria as agents for treating and preventing allergy |
| 09/11/2002 | EP1238986A2 Use of Vascular endothelial cell growth factor antagonists |
| 09/11/2002 | EP1238983A1 "Babesia canis vaccine" |
| 09/11/2002 | EP1238282A2 Methods of diagnosis and treatment by binding p75/airm1 |
| 09/11/2002 | EP1238281A2 Cancer associated antigens and uses therefor |
| 09/11/2002 | EP1238087A2 Porcine endovirus gag and env and diagnostic uses thereof |
| 09/11/2002 | EP1238086A1 Method of enhancing immune responses to herpes simplex virus vaccine |
| 09/11/2002 | EP1238084A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/11/2002 | EP1238082A2 Ifn-alpha homologues |
| 09/11/2002 | EP1238080A2 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 09/11/2002 | EP1238078A2 Clasp-4 transmembrane protein |
| 09/11/2002 | EP1238077A1 Tnfr/opg-like molecules and uses thereof |
| 09/11/2002 | EP1238075A2 Chordin-like molecules and uses thereof |
| 09/11/2002 | EP1238066A2 Masp-3, a complement-fixing enzyme, and uses for it |
| 09/11/2002 | EP1238061A2 A new genotype of hepatitis b virus |
| 09/11/2002 | EP1237930A2 Chimeric peptides (short b-cell epitope joined to a t-cell epitope) and their use for immunization |
| 09/11/2002 | EP1237929A1 Dendritic cell-specific antibodies |
| 09/11/2002 | EP1237928A1 Improvement of therapeutic potential of immunoglobulin preparations |